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Estrogen effects on triglyceride metabolism in analbuminemic Plasma triglyceride (TG) levels are usually lower in
rats. female than in male Sprague-Dawley (SD) rats [1], while
Background. Triglyceride (TG) levels are normally lower the opposite is true in Nagase analbuminemic rats (NAR)
in female rats, while the opposite is the case in the Nagase
[2, 3]. Lipoprotein lipase (LpL) is the enzyme responsibleanalbuminemic rats (NAR). Increased TG levels in normal
for the initial delipidation of TG-rich lipoproteins suchmales are caused by a testosterone-mediated decrease in post-
heparin (PH) lipoprotein lipase (LpL). Castration of males as chylomicrons (CM) and very-low density lipoprotein
reduces TG, while castration of females is without effect. TG (VLDL). The biologically active LpL pool is tethered to
levels are reduced by castration of the female NAR, suggesting the vascular endothelial cells by electrostatic interaction
that estrogen rather than testosterone causes hypertriglyceride-
with heparan sulfate. This pool is heparin releasable andmia in this strain. The mechanism for this increase is unknown.
is called the postheparin LpL pool (PH-LpL) [4]. TheMethods. We measured secretion of very-low density lipo-
measurement of LpL and hepatic lipase (HL) activity inprotein (VLDL) TG using Triton WR 1339 clearance as the
disappearance from blood of 3H-trioleate and 14C-cholesterol– plasma before and after heparin treatment has been used
labeled chylomicrons (CM), and the activity of the PH lipases: to estimate the pool size of biologically active lipase and
LpL and hepatic lipase (HL). All were determined in Sprague- is referred to as PH-LpL or PH-HL. Plasma PH-lipaseDawley (SD) and NAR female, male, and ovariectomized
values vary with hormonal status. The activity of PH-LpL(OVX) rats.
is greater in female SD rats than in males [5]. CastrationResults. TG levels were significantly greater in female NAR
in comparison to all other groups. Ovariectomy of NAR sig- of male rats increases PH-LpL activity, and testosterone
nificantly ameliorated hypertriglyceridemia. VLDL TG secre- administration to males, castrated males, and females
tion was significantly greater in intact female NAR compared decreases PH-LpL activity [1], but neither ovariectomy
with all other groups. There were no other differences in VLDL
nor estrogen administration to castrated male or femaleTG secretion among the other groups. The clearance of CM
has an effect on PH-LpL activity [1]. Conversely, estro-was greatest in female SD rats, and OVX had no effect. NAR
gen reduces PH-HL activity in vivo [6, 7]. These observa-cleared CM less well than did SD rats (P , 0.001), but among
NAR, clearance was greatest in OVX NAR and male NAR tions suggest that one mechanism for greater TG levels
(P , 0.002). Both PH LpL activity and HL activity were lowest in normal males is a testosterone-mediated decrease in
in female NAR (P , 0.05). Ovariectomy partially corrected PH-LpL activity.the defect in HL (P , 0.05).
In contrast to SD rats, TG levels are increased inConclusion. TG levels in female NAR are in part a result of
NAR, especially female NAR [8, 9], as well as rats withincreased VLDL-TG secretion, an effect mediated by estrogen.
The presence of an estrogen-mediated catabolic defect that experimentally induced nephrotic syndrome and Zucker
was alleviated by OVX was also observed. This catabolic defect obese rats [10]. The reversal of the normal pattern of
is likely a result of an estrogen-mediated decrease both in LpL lower TG levels in females may be a consequence of
and HL expressed only in the presence of analbuminemia.
increased TG synthesis in these altered metabolic states.
Women given unopposed estrogens typically show a mild
increase in plasma TG [11], but some develop severeKey words: lipoprotein lipase, hepatic lipase, very low density lipopro-
tein, analbuminemia, catabolism. hyperlipidemia [12, 13]. Increases in plasma TG under
these conditions are mediated by increased hepatic TGReceived for publication August 12, 1999
secretion in both humans and rats without a correspond-and in revised form November 17, 1999
Accepted for publication January 7, 2000 ing increase in fractional catabolic rate [14, 15]. It is
possible that under conditions when the mechanisms forÓ 2000 by the International Society of Nephrology
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removal of TG rich lipoproteins are impaired, the estro- University of California, Davis, and the Utrecht Univer-
sity animal study boards.genic effects on TG secretion become unmasked, leading
to marked increases in plasma TG levels.
Chemical analysisHypertriglyceridemia caused by defective catabolism
is a risk factor for the development of atherosclerosis in Enzymatic kits were used for the determination of
plasma TG concentrations (kit #148-270; Boehringerwomen [16] and for renal disease [17, 18]. Obese Zucker
rats are a genetically hypertriglyceridemic breed that GmbH, Mannheim, Germany; and kit #339-10; Sigma,
St. Louis, MO, USA).spontaneously develops renal failure. Within this strain,
the onset of proteinuria and renal failure is accelerated
Triglyceride secretion ratein females [10]. Ovariectomy reduces TG levels in female
Zucker-obese rats compared with that found in males Triton WR-1339 is a nonionic detergent that blocks
the removal of TG from the circulation, causing a linearand delays the onset of renal failure [10]. Aging female
NAR, but not male NAR or OVX NAR, also develop increase in the plasma TG concentration. The rate of
this increase is a measure of total TG secretion rate. Theproteinuria and glomerulosclerosis [9]. Renal injury in
NAR appears to be estrogen dependent and is unique TG secretion rate was determined in 22 SD rats (6 female
SD, 6 OVX SD, and 10 male SD rats) and 20 NAR (7in that hypertriglyceridemia is the only known risk factor
to present before proteinuria develops [19]. female NAR, 7 OVX NAR, and 6 male NAR) after an
overnight fast. Six hundred mg/kg Triton WR-1339 inWe previously demonstrated that TG secretion was
increased in female NAR compared with female SD rats 0.9% saline were injected into the tail vein. Plasma sam-
ples were taken just prior to injection and at 30-, 60-,[8]. Moreover, as noted earlier, plasma TG is higher in
female NAR than in male NAR. Increased TG levels and 90-minutes postinjection. The time points were sub-
jected to linear regression analysis, and the secretion ratemust be a consequence of either increased synthesis,
decreased catabolism, or a combination of both. It is not was determined as the predicted hourly accumulation of
plasma TG.known how the catabolism of TG-rich lipoproteins is
affected by gender in NAR and whether the effects,
Heparin releasable LpL and HL activityif any, are mediated by estrogen. We measured both
secretion and catabolism of TG-rich lipoproteins in OVX Postheparin lipase was determined in 16 SD rats (4
female SD, 6 OVX SD, and 6 male SD rats) and 13SD animals and NAR and compared them with those
of intact male and females. We also measured the known NAR (6 female NAR, 4 OVX NAR, and 3 male NAR)
after an overnight fast. Rats were anesthetized with anparameters affecting TG-rich lipoprotein metabolism,
such as the levels of HL and LpL. intraperitoneal injection of 0.75 g/kg of sodium pentobar-
bital. Fifty U/kg heparin were injected intravenously,
and five minutes later, blood was collected by aortic
METHODS
puncture into a tube containing ethylenediaminetetra-
Animals acetic acid (EDTA). The plasma was separated and
stored at 2708C until assayed.Sprague-Dawley rats were purchased from Bantin
Kingman (N 5 33; Fremont, CA, USA) for the experi- Lipoprotein lipase activity was assessed using a proto-
col adapted from Kraus, Levy, and Fredrickson [20]. Tenments in Davis (CA, USA), and from Harlan-Orlac (N 5
22; UK) for the experiments in Utrecht. NAR (N 5 51) mCi of glycerol [9,10-3H] trioleate, 1.5 mg phosphatidyl
choline, and 37.5 mg triolein in chloroform solution werewere from our own pathogen-free colonies in Utrecht
and Davis. The Davis colony was founded with animals combined in a 50 3 16 mm tube and then dried com-
pletely under N2. The test substrate was formed by com-obtained from the Utrecht colony in 1993 and were bred
in Davis. bining 2.8 mL substrate buffer (0.2 mol/L Tris, 0.150
mol/L NaCl, pH to 8.6), 1.2 mL 10% fatty acid-freeSeventeen SD rats and 17 NAR were bilaterally ovari-
ectomized (OVX) at five weeks under pentobarbital an- bovine serum albumin (BSA) in substrate buffer, 0.25
mL 1% Triton X-100 in substrate buffer, and 0.25 mLesthesia and sterile conditions. The remaining females
were sham operated without excision of the ovaries. The fasting heat-inactivated human plasma in a tube. The
mixture was then sonicated on ice using a Branson Soni-rats were housed behind barriers in temperature regu-
lated, 12-hour light/dark cycled rooms. The rats were fier 250 for five minutes at power output 5 and 50% duty.
Heparin releases both LpL and HL, but LpL is inhib-provided with free access to standard rat chow until
the evening before the experiments. Seven weeks after ited by 1.0 mol/L NaCl. Thus, plasma LpL was measured
as the difference between total lipase activity and lipaseovariectomy, the vascular clearance of CM and heparin-
releasable lipase was measured in the group at Davis, activity in the presence of 1.0 mol/L NaCl. HL activity
was measured directly as the lipase activity not inhibitedand VLDL-TG secretion rates were measured in the
group at Utrecht. The protocols were approved by the by 1 mol/L NaCl. Tests and their respective blanks were
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prepared by the addition of 0.1 mL of the labeled emul-
sion to 0.4 mL of sample diluted in phosphate-buffered
saline (PBS) 1 0.5% BSA or 0.5% BSA alone. Both
tests and blanks were incubated for 30 minutes at 378C.
The reaction was stopped by the addition of 1.62 mL
chloroform/MeOH/heptane (1.25:1.41:1.00) to each tube.
The tubes were vortexed, and 0.50 mL of 0.4 mol/L boric
acid/0.4 mol/L K2CO3, pH 10.0, was added. The samples
were vortexed again for 15 seconds and then centrifuged
for 10 minutes at 1000 3 g to separate phases. One milli-
liter of the top phase was counted in liquid scintillation
fluid on a Beckman Scintillation counter. Total emulsion
radioactivity was determined by counting 0.1 mL emul-
sion. A standard curve relating LpL activity to LpL mass
Fig. 1. Plasma triglyceride levels in male, female, and ovariectomizedwas created by measuring the radioactivity released from (OVX) Sprague-Dawley (SD) rats and Nagase analbuminemic rats
0.1 mL aliquots of emulsion by increasing the amounts (NAR). Mean plasma triglycerides levels were measured from tail blood
of rats fasted for 16 hours. Intact females (Fem), OVX females, andof purified LpL. The curve was linear with respect to
males are represented from each breed. Error bars represent SEM.
LpL mass (r2 5 0.950). †P , 0.05 vs. female SD; ‡P , 0.05 vs. female NAR, female SD; P ,
0.05 vs. female NAR, OVX NAR, female SD.
Preparation of chylomicrons
Radiolabeled CMs were obtained by the method of
Statistical analysisBollman, Cain, and Grindlay [21]. Rats were gavage fed
a 2 mL emulsified prep of corn oil/milk (1:2) sonicated Differences between experimental groups were deter-
with glycerol [9,10-3H] trioleate (0.15 mCi) and [14C] cho- mined by one-way analysis of variance (ANOVA), ex-
lesterol (0.05 mCi). The thoracic duct was cannulated, cept for analysis of CM and TG clearance in which two-
way ANOVA was used. If significant differences wereand chyle was collected on ice for 18 hours. CMs were
determined (P , 0.05), the differences of the meansisolated by layering the chyle under 0.15 mol/L NaCl
were analyzed by the posthoc Student-Newman-Keulsand flotation on a SW-40ti rotor (Beckman Instruments,





Seventeen SD rats (6 female SD, 5 SD OVX, and 6 Plasma TGs were significantly greater in female NAR
male SD rats) and 18 NAR (6 female NAR, 6 OVX than in OVX NAR (P , 0.05). While ovariectomy re-
NAR, and 6 male NAR) were fasted overnight, and duced TG levels, this was insufficient to reach the levels
blood was obtained by tail bleed prior to injection to found in male NAR (P , 0.05). Plasma TG levels in
determine fasting TG levels. Labeled CMs were injected male NAR were not significantly different from that in
into a tail vein, and blood samples were subsequently male SD rats. TG levels in female NAR were significantly
sampled in duplicate at 2-, 4-, 6-, 8-, 10-, 12-, and 15- greater than in female SD rats (P , 0.001). In contrast
to the pattern observed in NAR, TG levels were 50%minutes postinjection. Lipids were extracted by the
greater in SD males than in SD females, and OVX causedmethod of Dole, as modified by Trout, Estes, and Freid-
a 25% increase in TG levels in females. However, theseberg [22]. The extracts were counted in a liquid scintilla-
changes were not statistically significant (Fig. 1).tion counter for 10 minutes. CM clearance curves were
calculated by linear regression using the method of least VLDL-TG secretion
squares on the natural log of percentage remaining
Very-low density lipoprotein-TG secretion was great-counts versus elapsed time. The half-life of disappear-
est in female NAR and differed significantly from all of
ance (t1/2) was determined as ln (2)/b, where b is the the other groups (P , 0.05; Fig. 2). VLDL-TG secretion
determined rate constant. Unlike t1/2, b is normally dis- was the same in OVX NAR, male NAR, and all three
tributed and was used for statistical analysis. Results groups of SD rats.
are reported in t1/2 since this value is more intuitive. To
Heparin releasable LpL and HL activitydetermine whether significant differences existed be-
tween clearance of TG (3H) and cholesterol (14C), we Postheparin LpL activity in SD rats was unaffected
by gender, but OVX resulted in a 1.4-fold increase inused Db for each animal.
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Fig. 2. Plasma very-low density lipoprotein (VLDL) secretion rates in
male, female, and ovariectomized SD rats and NAR. The mean VLDL
TG secretion rates were measured from TG concentration in serum
from tail blood of fasted rats following an injection of 600 mg/kg Triton
WR 1339. Intact females (Fem), ovariectomized females (OVX), and
males are represented from each breed. Error bars represent SEM.
†P , 0.05 vs. female SD; ‡P , 0.05 vs. female NAR.
PH-LpL activity (P , 0.05; Fig. 3). PH-LpL activity was
greatly reduced in all NAR (P , 0.0005). In NAR, PH-
LpL activity did not exceed 10% of the activity found
in their SD counterparts. As with SD rats, PH-LpL activ-
ity in OVX NAR tended to be greater than in female
NAR (P 5 ~0.03, uncorrected). This increase ap-
proached but did not reach significance. Female NAR
Fig. 3. Postheparin lipase activity. Plasma lipase activity at five minuteshad virtually no PH-LpL activity (Fig. 3A). following injection of 50 U heparin/kg. (A) Lipase activity inhibited by
In NAR, PH-HL activity was also reduced versus SD 1 mol/L NaCl. (B) Lipase activity not inhibited by 1 mol/L NaCl. Intact
females, ovariectomized females (OVX), and males are representedrats (P , 0.001). In female NAR, PH-HL activity was
from each breed. Error bars represent SEM. †P , 0.001 vs. all SD;reduced compared with all SD rats (P , 0.05), but OVX ‡P , 0.05 vs. female SD; *P , 0.05 vs. female, OVX SD; **P , 0.05
NAR and male NAR were only less than female SD and vs. SD male.
OVX SD rats (P , 0.05) and were not different from
male SD (Fig. 3B).
Chylomicron clearance significantly different from zero for each treatment
group. We found that Db was not different from zeroClearance of CM-TG and CM-cholesterol (CM-chol)
for each NAR group (female NAR 5 20.009 6 0.005,were analyzed for the effects of treatment group versus
male NAR 5 20.018 6 0.005, OVX NAR 5 20.016 6lipid using two-way ANOVA. CM-TG clearance was
0.006), but it was less than zero for all SD rats (femalesignificantly greater in female SD rats than in male SD
SD 5 20.126 6 0.011, SD male 5 20.049 6 0.005, SDrats (P , 0.005), and OVX had no effect (Fig. 4). CM-
OVX 5 20.107 6 0.019, P , 0.05). Among SD, Db wasTG clearance was significantly lower in all NARs (P ,
less in female SD than in male, and ovariectomy had no0.05). CM-TG clearance was not significantly greater in
effect (P , 0.05).female NAR than in male NAR, but CM-TG clearance
When the effect of both CM-TG and CM-chol wasin NAR OVX was significantly greater than either male
combined, the effect of CM-lipid clearance was evenor female NAR (P , 0.05; Fig. 4).
more pronounced. Clearance CM-lipids were greatest inChylomicron-cholesterol (CM-chol) clearance was sig-
female SD rats, and ovariectomy had no effect (P ,nificantly reduced in all NAR versus female and OVX
0.05). Clearance was significantly reduced in SD maleSD rats (P , 0.05), but only female NAR CM-chol clear-
rats (P , 0.05). Among NAR, CM lipid clearance wasance was reduced compared with SD males (P , 0.05;
greatest in male NAR (P , 0.05) but was significantlyFig. 5). To determine the relationship between TG and
cholesterol clearance, we first analyzed whether Db was less than SD male rats (P , 0.05), while female NAR
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Fig. 4. Chylomicron triglyceride (TG) catab-
olism. Disappearance of label from rat blood
after tail vein injection of labeled chylomi-
crons as measured by log10 (counts remaining).
The t1/2 is in minutes. Error bars represent
SEM for each time point. †P , 0.001 vs. all
SD; §P , 0.05 vs. female and OVX SD; ‡P ,
0.05 vs. female and male NAR.
Fig. 5. Chylomicron cholesterol catabolism.
Disappearance of glycerol [9,10-3H] trioleate
from rat blood after tail vein injection of la-
beled chylomicrons as measured by log10
(counts remaining). The t1/2 is in minutes. Er-
ror bars represent SEM for each time point.
†P , 0.001 vs. all SD; §P , 0.05 vs. female
and OVX SD.
clearance was the least of all treatment groups (P , The decrease in clearance of CM (and by extension of
VLDL) is quite mild when compared with what occurs0.05). Among NAR, the effect of ovariectomy on total
in the nephrotic syndrome [25], and the degree of hyper-CM-lipid clearance was to significantly increase it to male
lipidemia, especially in the males, is correspondingly lessNAR levels (P , 0.05).
than seen in males with nephrotic syndrome [2].
Female NAR have greater lipid levels than do male
DISCUSSION NAR [2, 3] This pattern is the opposite of what occurs
The NAR is characterized by an almost complete lack in normal SD rats. Our findings confirm this reversed
of plasma albumin, which is replaced by a number of pattern of TG levels in NAR, and they confirm that
mostly high molecular weight proteins [23]. Consequently, estrogen mediates this reversal. In female NAR, lipid
NAR also exhibit reduced plasma oncotic pressure (p). levels increase with age, and this is corrected by OVX [9].
Included in the abnormalities in plasma protein composi- We found that ovariectomy did not completely abolish
tion is an increase in lipoprotein levels, but unlike the case hypertriglyceridemia in female NAR, suggesting an im-
of other proteins, a decrease in the fractional catabolic portant but not exclusive role of estrogen in mediating
rate of lipoproteins, including high-density lipoprotein their increased TG levels.
There are two possible causes of increased TG levels(HDL) [24], contributes to their increased level in plasma.
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in female NAR: increased hepatic TG secretion or de- by receptors in the liver. HL mediates this process by
creased catabolism of TG-containing lipoproteins. In tethering the remnant to heparan sulfate proteoglycans,
normal rats, estrogen causes increased hepatic produc- aiding uptake of the remnant by hepatic apoE receptors
tion of VLDL [14, 26], and this clearly also occurs in [33]. The delay in clearance of CM-TG (3H) in female,
NAR. TG secretion is increased only in female NAR, male, and OVX NAR is not different from the delay in
not in OVX, suggesting that increased TG levels in these CM-chol (14C) clearance. This finding along with the
animals are at least in part the result of increased TG severe PH-LpL depletion suggests that minimally lipo-
secretion mediated by estrogen. Estrogen-mediated in- lyzed particles are cleared intact in NAR, or fully lipo-
creased TG synthesis in normal women is responsible lyzed remnants are cleared immediately. Indeed, there
for the slight increase in TG levels of about 15 mg/dL. is a greater delay between delipidation (3H clearance)
However, when there are other factors that also predis-
and remnant uptake (14C clearance) in SD rats than in
pose to hyperlipidemia, the effects of estrogen can be
NAR, suggesting that at the very least there is no addi-far greater [12, 27] and can be life threatening [28, 29].
tional impedance to the uptake of remnant particles inThe effect of estrogen on TG secretion exacerbates se-
NAR. The lack of peripheral lipase increases the impor-rum TG levels in NAR, which are also predisposed to
tance of HL, presumably both in its role as a TG lipasehyperlipidemia.
and as a mediator of remnant clearance, the presenceThis predisposition in all NAR is a result of reduced
of HL is pivotal in maintenance of serum TG in NAR.TG catabolism. In this study, we found greatly reduced
Estrogen worsened levels of HL and, similarly, the clear-levels of PH lipase in NAR, especially of LpL. Despite
ance of CM lipids, providing evidence for this hypothesis.a trend of increased PH-LpL in OVX NAR, the LpL
In the case of NAR total lipid clearance, the effect ofdepletion was an effect of analbuminemia. Thus, the
large lipase pool in SD arts allows for the normoalbumi- estrogen exacerbated already defective clearance, lead-
nemic female animals to offset increased hepatic secre- ing to greatly prolonged lipid clearance as the catabolic
tion by increase catabolism. Increased secretion in fe- defect was corrected by ovariectomy. Thus, estrogen
male NAR cannot be offset in this way. worsens the already deficient clearance, while the pres-
Estrogen protects postmenopausal women from car- ence of estrogen in SD did not adversely affect lipid
diovascular disease by increasing HDL and lowering clearance; however, SD animals do not lack lipolytic
LDL levels, despite mildly increasing plasma TG levels. capacity, as evidenced by high peripheral LpL levels and
Both increases in HDL and decreases in LDL are the presence of a discrete mechanism for the removal
thought to derive in part from decreased HL activity of CM-TG and CM-chol.
[30]. These potentially salutary changes in lipoprotein While estrogen hormone replacement clearly is bene-
profile do not occur in NAR. Despite an almost complete
ficial to women, in certain instances, this may not be so.
PH-LpL depletion in NAR in the absence of estrogen,
Hypertriglyceridemia is emerging as a risk factor forPH-HL activity is not reduced, and even when estrogen
glomerulosclerosis [17, 18], and hyperlipidemia contrib-is present, it is not reduced to the same extent as is LpL,
utes to renal injury in female NAR [19] and in the Obesesuggesting that estrogen’s effects on HL are similar in
Zucker rat [10]. Estrogen causes increased lipid levels,NAR as in normal animals. HL represents the greatest
and the hyperlipidemia causes profound renal injury inlipolytic potential for clearance of TG in NAR. Estrogen
these models [19, 34]. These results contrast with findingsthen would reduce HL and be expected to reduce CM
in normal animals in which the progression of renal dis-rather than increase CM clearance as it does in normal
ease is less severe in females [35]. It may be worthwhileanimals, where estrogen also increases LpL. This latter
to also examine whether estrogen administration to indi-mechanism does not occur to any biologically relevant
extent in analbuminemia. viduals having reduced plasma albumin concentration
In female SD rats, the lower serum TGs are a result affords any benefit to blood lipid profiles.
of increased clearance, which is most likely a conse-
quence of increased PH-LpL [1]. Testosterone in SD ACKNOWLEDGMENTS
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